◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

10-Q Filing

BIO-TECHNE CORP CIK: 842023 Q1 2022
Filing Information
Form Type 10-Q
Accession Number 0001437749-21-025721
Period End Date 20210930
Filing Date 20211108
Fiscal Year 2022
Fiscal Period Q1
XBRL Instance tech20210930_10q_htm.xml
Filing Contents

This filing contains the following financial statements:

Balance Sheet 92 line items
Line Item Tag Value Unit Period
Accounts receivable, allowance for doubtful accounts AllowanceForDoubtfulAccountsReceivableCurrent $1.27M USD Point-in-time
Accounts receivable, allowance for doubtful accounts AllowanceForDoubtfulAccountsReceivableCurrent $1.23M USD Point-in-time
Undesignated capital stock, no par (in dollars per share) UndesignatedCapitalStockNoParValue - USD Point-in-time
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue $199.09M USD Point-in-time
Undesignated capital stock, no par (in dollars per share) UndesignatedCapitalStockNoParValue - USD Point-in-time
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue $196.32M USD Point-in-time
Undesignated capital stock, shares authorized (in shares) UndesignatedCapitalStockSharesAuthorized 5.00M shares Point-in-time
Undesignated capital stock, shares authorized (in shares) UndesignatedCapitalStockSharesAuthorized 5.00M shares Point-in-time
Short-term available-for-sale investments AvailableForSaleSecuritiesDebtSecuritiesCurrent $38.74M USD Point-in-time
Short-term available-for-sale investments AvailableForSaleSecuritiesDebtSecuritiesCurrent $32.46M USD Point-in-time
Accounts receivable, less allowance for doubtful accounts of $1,273 and $1,229, respectively AccountsReceivableNetCurrent $147.55M USD Point-in-time
Undesignated capital stock, shares issued (in shares) UndesignatedCapitalStockSharesIssued 0.00 shares Point-in-time
Accounts receivable, less allowance for doubtful accounts of $1,273 and $1,229, respectively AccountsReceivableNetCurrent $145.38M USD Point-in-time
Undesignated capital stock, shares issued (in shares) UndesignatedCapitalStockSharesIssued 0.00 shares Point-in-time
Inventories InventoryNet $116.75M USD Point-in-time
Undesignated capital stock, shares outstanding (in shares) UndesignatedCapitalStockSharesOutstanding 0.00 shares Point-in-time
Inventories InventoryNet $117.37M USD Point-in-time
Undesignated capital stock, shares outstanding (in shares) UndesignatedCapitalStockSharesOutstanding 0.00 shares Point-in-time
Common stock, par value (in dollars per share) CommonStockParOrStatedValuePerShare $0.01 USD Point-in-time
Other current assets OtherAssetsCurrent $16.92M USD Point-in-time
Other current assets OtherAssetsCurrent $43.77M USD Point-in-time
Common stock, par value (in dollars per share) CommonStockParOrStatedValuePerShare $0.01 USD Point-in-time
Common stock, shares authorized (in shares) CommonStockSharesAuthorized 100.00M shares Point-in-time
Common stock, shares authorized (in shares) CommonStockSharesAuthorized 100.00M shares Point-in-time
Total current assets AssetsCurrent $510.61M USD Point-in-time
Total current assets AssetsCurrent $543.75M USD Point-in-time
Property and equipment, net PropertyPlantAndEquipmentNet $207.13M USD Point-in-time
Property and equipment, net PropertyPlantAndEquipmentNet $207.91M USD Point-in-time
Common stock, shares issued (in shares) CommonStockSharesIssued 38.96M shares Point-in-time
Common stock, shares issued (in shares) CommonStockSharesIssued 39.27M shares Point-in-time
Right of use asset OperatingLeaseRightOfUseAsset $73.83M USD Point-in-time
Right of use asset OperatingLeaseRightOfUseAsset $71.40M USD Point-in-time
Common stock, shares outstanding (in shares) CommonStockSharesOutstanding 38.96M shares Point-in-time
Common stock, shares outstanding (in shares) CommonStockSharesOutstanding 39.27M shares Point-in-time
Goodwill Goodwill $840.02M USD Point-in-time
Goodwill Goodwill $843.07M USD Point-in-time
Intangible assets, net IntangibleAssetsNetExcludingGoodwill $596.30M USD Point-in-time
Intangible assets, net IntangibleAssetsNetExcludingGoodwill $615.97M USD Point-in-time
Other assets OtherAssetsNoncurrent $11.57M USD Point-in-time
Other assets OtherAssetsNoncurrent $11.59M USD Point-in-time
Total assets Assets $2.26B USD Point-in-time
Total assets Assets $2.27B USD Point-in-time
Trade accounts payable AccountsPayableCurrent $29.38M USD Point-in-time
Trade accounts payable AccountsPayableCurrent $25.62M USD Point-in-time
Salaries, wages and related accruals EmployeeRelatedLiabilitiesCurrent $51.29M USD Point-in-time
Salaries, wages and related accruals EmployeeRelatedLiabilitiesCurrent $32.21M USD Point-in-time
Accrued expenses AccruedLiabilitiesCurrent $17.42M USD Point-in-time
Accrued expenses AccruedLiabilitiesCurrent $15.28M USD Point-in-time
Contract liabilities ContractWithCustomerLiabilityCurrent $19.12M USD Point-in-time
Contract liabilities ContractWithCustomerLiabilityCurrent $19.00M USD Point-in-time
Income taxes payable AccruedIncomeTaxesCurrent $6.50M USD Point-in-time
Income taxes payable AccruedIncomeTaxesCurrent $5.34M USD Point-in-time
Operating lease liabilities - current OperatingLeaseLiabilityCurrent $12.00M USD Point-in-time
Operating lease liabilities - current OperatingLeaseLiabilityCurrent $11.60M USD Point-in-time
Contingent consideration payable BusinessCombinationContingentConsiderationLiabilityCurrent $4.00M USD Point-in-time
Contingent consideration payable BusinessCombinationContingentConsiderationLiabilityCurrent $5.00M USD Point-in-time
Current portion of long-term debt obligations LongTermDebtCurrent $12.50M USD Point-in-time
Current portion of long-term debt obligations LongTermDebtCurrent $12.50M USD Point-in-time
Other current liabilities OtherLiabilitiesCurrent $3.89M USD Point-in-time
Other current liabilities OtherLiabilitiesCurrent $3.61M USD Point-in-time
Total current liabilities LiabilitiesCurrent $133.99M USD Point-in-time
Total current liabilities LiabilitiesCurrent $152.28M USD Point-in-time
Deferred income taxes DeferredIncomeTaxLiabilitiesNet $93.12M USD Point-in-time
Deferred income taxes DeferredIncomeTaxLiabilitiesNet $98.81M USD Point-in-time
Long-term debt obligations LongTermDebtAndCapitalLeaseObligations $287.72M USD Point-in-time
Long-term debt obligations LongTermDebtAndCapitalLeaseObligations $328.83M USD Point-in-time
Long-term contingent consideration payable BusinessCombinationContingentConsiderationLiabilityNoncurrent $25.40M USD Point-in-time
Long-term contingent consideration payable BusinessCombinationContingentConsiderationLiabilityNoncurrent $17.60M USD Point-in-time
Operating lease liabilities OperatingLeaseLiabilityNoncurrent $67.62M USD Point-in-time
Operating lease liabilities OperatingLeaseLiabilityNoncurrent $65.06M USD Point-in-time
Other long-term liabilities OtherLiabilitiesNoncurrent $20.05M USD Point-in-time
Other long-term liabilities OtherLiabilitiesNoncurrent $24.46M USD Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding UndesignatedCapitalStockValue - USD Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding UndesignatedCapitalStockValue - USD Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 39,273,057 and 38,955,484, respectively CommonStockValue $390.00K USD Point-in-time
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 39,273,057 and 38,955,484, respectively CommonStockValue $393.00K USD Point-in-time
Additional paid-in capital AdditionalPaidInCapitalCommonStock $534.41M USD Point-in-time
Additional paid-in capital AdditionalPaidInCapitalCommonStock $583.85M USD Point-in-time
Retained earnings RetainedEarningsAccumulatedDeficit $1.09B USD Point-in-time
Retained earnings RetainedEarningsAccumulatedDeficit $1.12B USD Point-in-time
Accumulated other comprehensive loss AccumulatedOtherComprehensiveIncomeLossNetOfTax $-64.22M USD Point-in-time
Accumulated other comprehensive loss AccumulatedOtherComprehensiveIncomeLossNetOfTax $-57.29M USD Point-in-time
Total Bio-Techne's shareholders' equity StockholdersEquity $1.64B USD Point-in-time
Total Bio-Techne's shareholders' equity StockholdersEquity $1.56B USD Point-in-time
Noncontrolling interest MinorityInterest $8.26M USD Point-in-time
Noncontrolling interest MinorityInterest $7.59M USD Point-in-time
Total shareholder's equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $1.57B USD Point-in-time
Total shareholder's equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $1.44B USD Point-in-time
Total shareholder's equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $1.38B USD Point-in-time
Total shareholder's equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $1.65B USD Point-in-time
Total liabilities and shareholders equity LiabilitiesAndStockholdersEquity $2.26B USD Point-in-time
Total liabilities and shareholders equity LiabilitiesAndStockholdersEquity $2.27B USD Point-in-time
Income Statement 46 line items
Line Item Tag Value Unit Period
Net sales RevenueFromContractWithCustomerExcludingAssessedTax $257.72M USD 1 Quarter
Net sales RevenueFromContractWithCustomerExcludingAssessedTax $204.20M USD 1 Quarter
Cost of sales CostOfGoodsAndServicesSold $86.72M USD 1 Quarter
Cost of sales CostOfGoodsAndServicesSold $66.47M USD 1 Quarter
Gross margin GrossProfit $171.00M USD 1 Quarter
Gross margin GrossProfit $137.73M USD 1 Quarter
Selling, general and administrative SellingGeneralAndAdministrativeExpense $72.60M USD 1 Quarter
Selling, general and administrative SellingGeneralAndAdministrativeExpense $86.17M USD 1 Quarter
Research and development ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost $21.60M USD 1 Quarter
Research and development ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost $16.04M USD 1 Quarter
Total operating expenses OperatingExpenses $88.64M USD 1 Quarter
Total operating expenses OperatingExpenses $107.78M USD 1 Quarter
Operating income OperatingIncomeLoss $63.22M USD 1 Quarter
Operating income OperatingIncomeLoss $49.09M USD 1 Quarter
Other income (expense) NonoperatingIncomeExpense $4.16M USD 1 Quarter
Other income (expense) NonoperatingIncomeExpense $-9.75M USD 1 Quarter
Earnings before income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $67.38M USD 1 Quarter
Earnings before income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $39.34M USD 1 Quarter
Income taxes (benefit) IncomeTaxExpenseBenefit $5.94M USD 1 Quarter
Income taxes (benefit) IncomeTaxExpenseBenefit $-1.60M USD 1 Quarter
Net earnings, including noncontrolling interest ProfitLoss $33.40M USD 1 Quarter
Net earnings, including noncontrolling interest ProfitLoss $68.98M USD 1 Quarter
Net earnings (loss) attributable to noncontrolling interest NetIncomeLossAttributableToNoncontrollingInterest - USD 1 Quarter
Net earnings (loss) attributable to noncontrolling interest NetIncomeLossAttributableToNoncontrollingInterest $-634.00K USD 1 Quarter
Net earnings attributable to Bio-Techne NetIncomeLoss $33.40M USD 1 Quarter
Net earnings attributable to Bio-Techne NetIncomeLoss $69.61M USD 1 Quarter
Foreign currency translation adjustments OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent $-8.65M USD 1 Quarter
Foreign currency translation adjustments OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent $11.91M USD 1 Quarter
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8 OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent $2.14M USD 1 Quarter
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8 OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent $1.68M USD 1 Quarter
Other comprehensive income (loss) OtherComprehensiveIncomeLossNetOfTax $-6.96M USD 1 Quarter
Other comprehensive income (loss) OtherComprehensiveIncomeLossNetOfTax $14.06M USD 1 Quarter
Other comprehensive income (loss) attributable to noncontrolling interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest $-39.00K USD 1 Quarter
Other comprehensive income (loss) attributable to noncontrolling interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest - USD 1 Quarter
Other comprehensive income (loss) attributable to Bio-Techne OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $14.06M USD 1 Quarter
Other comprehensive income (loss) attributable to Bio-Techne OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $-6.92M USD 1 Quarter
Comprehensive income attributable to Bio-Techne ComprehensiveIncomeNetOfTax $62.69M USD 1 Quarter
Comprehensive income attributable to Bio-Techne ComprehensiveIncomeNetOfTax $47.45M USD 1 Quarter
Basic (in dollars per share) EarningsPerShareBasic $1.78 USD 1 Quarter
Basic (in dollars per share) EarningsPerShareBasic $0.87 USD 1 Quarter
Diluted (in dollars per share) EarningsPerShareDiluted $0.83 USD 1 Quarter
Diluted (in dollars per share) EarningsPerShareDiluted $1.69 USD 1 Quarter
Basic (in shares) WeightedAverageNumberOfSharesOutstandingBasic 38.54M shares 1 Quarter
Basic (in shares) WeightedAverageNumberOfSharesOutstandingBasic 39.09M shares 1 Quarter
Diluted (in shares) WeightedAverageNumberOfDilutedSharesOutstanding 41.16M shares 1 Quarter
Diluted (in shares) WeightedAverageNumberOfDilutedSharesOutstanding 40.02M shares 1 Quarter
Cash Flow Statement 74 line items
Line Item Tag Value Unit Period
Net earnings, including noncontrolling interest ProfitLoss $33.40M USD 1 Quarter
Net earnings, including noncontrolling interest ProfitLoss $68.98M USD 1 Quarter
Depreciation and amortization DepreciationDepletionAndAmortization $21.09M USD 1 Quarter
Depreciation and amortization DepreciationDepletionAndAmortization $24.73M USD 1 Quarter
Costs recognized on sale of acquired inventory FairValueWriteUpOfAcquiredInventory - USD 1 Quarter
Costs recognized on sale of acquired inventory FairValueWriteUpOfAcquiredInventory $1.51M USD 1 Quarter
Deferred income taxes DeferredIncomeTaxesAndTaxCredits $5.41M USD 1 Quarter
Deferred income taxes DeferredIncomeTaxesAndTaxCredits $-452.00K USD 1 Quarter
Stock-based compensation expense ShareBasedCompensation $12.95M USD 1 Quarter
Stock-based compensation expense ShareBasedCompensation $11.74M USD 1 Quarter
Fair value adjustment to contingent consideration payable FairValueAdjustmentToContingentConsiderationPayable $-2.80M USD 1 Quarter
Fair value adjustment to contingent consideration payable FairValueAdjustmentToContingentConsiderationPayable $-150.00K USD 1 Quarter
Contingent consideration payments BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 $-3.30M USD 1 Quarter
Contingent consideration payments BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 - USD 1 Quarter
Fair value adjustment on available for sale investments FairValueAdjustmentOnAvailableForSaleSecurities $4.35M USD 1 Quarter
Fair value adjustment on available for sale investments FairValueAdjustmentOnAvailableForSaleSecurities $-5.28M USD 1 Quarter
Asset impairment restructuring AssetImpairmentCharges $546.00K USD 1 Quarter
Asset impairment restructuring AssetImpairmentCharges - USD 1 Quarter
Leases, net NoncashPortionOfLeaseExpense - USD 1 Quarter
Leases, net NoncashPortionOfLeaseExpense $-79.00K USD 1 Quarter
Other operating activity OtherOperatingActivitiesCashFlowStatement $195.00K USD 1 Quarter
Other operating activity OtherOperatingActivitiesCashFlowStatement $497.00K USD 1 Quarter
Trade accounts and other receivables, net IncreaseDecreaseInAccountsAndOtherReceivables $3.64M USD 1 Quarter
Trade accounts and other receivables, net IncreaseDecreaseInAccountsAndOtherReceivables $-910.00K USD 1 Quarter
Inventories IncreaseDecreaseInInventories $2.98M USD 1 Quarter
Inventories IncreaseDecreaseInInventories $1.97M USD 1 Quarter
Prepaid expenses IncreaseDecreaseInPrepaidExpense $-1.63M USD 1 Quarter
Prepaid expenses IncreaseDecreaseInPrepaidExpense $5.85M USD 1 Quarter
Trade accounts payable, accrued expenses, contract liabilities, and other IncreaseDecreaseInAccountsPayableAndAccruedLiabilities $-2.30M USD 1 Quarter
Trade accounts payable, accrued expenses, contract liabilities, and other IncreaseDecreaseInAccountsPayableAndAccruedLiabilities $6.92M USD 1 Quarter
Salaries, wages and related accruals IncreaseDecreaseInEmployeeRelatedLiabilities $-18.93M USD 1 Quarter
Salaries, wages and related accruals IncreaseDecreaseInEmployeeRelatedLiabilities $-11.48M USD 1 Quarter
Income taxes payable IncreaseDecreaseInAccruedIncomeTaxesPayable $-1.38M USD 1 Quarter
Income taxes payable IncreaseDecreaseInAccruedIncomeTaxesPayable $-19.82M USD 1 Quarter
Net cash provided by operating activities NetCashProvidedByUsedInOperatingActivities $48.43M USD 1 Quarter
Net cash provided by operating activities NetCashProvidedByUsedInOperatingActivities $66.01M USD 1 Quarter
Proceeds from maturities of available-for-sale investments ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities $12.45M USD 1 Quarter
Proceeds from maturities of available-for-sale investments ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities $29.04M USD 1 Quarter
Purchases of available-for-sale investments PaymentsToAcquireAvailableForSaleSecuritiesDebt $26.24M USD 1 Quarter
Purchases of available-for-sale investments PaymentsToAcquireAvailableForSaleSecuritiesDebt $13.50M USD 1 Quarter
Additions to property and equipment PaymentsToAcquirePropertyPlantAndEquipment $6.07M USD 1 Quarter
Additions to property and equipment PaymentsToAcquirePropertyPlantAndEquipment $10.94M USD 1 Quarter
Net cash provided by (used in) investing activities NetCashProvidedByUsedInInvestingActivities $-7.12M USD 1 Quarter
Net cash provided by (used in) investing activities NetCashProvidedByUsedInInvestingActivities $-8.14M USD 1 Quarter
Cash dividends PaymentsOfDividendsCommonStock $12.34M USD 1 Quarter
Cash dividends PaymentsOfDividendsCommonStock $12.49M USD 1 Quarter
Proceeds from stock option exercises ProceedsFromStockOptionsExercised $15.42M USD 1 Quarter
Proceeds from stock option exercises ProceedsFromStockOptionsExercised $37.88M USD 1 Quarter
Borrowings under line-of-credit agreement ProceedsFromLongTermLinesOfCredit - USD 1 Quarter
Borrowings under line-of-credit agreement ProceedsFromLongTermLinesOfCredit $10.00M USD 1 Quarter
Repayments of long-term debt RepaymentsOfLinesOfCredit $51.12M USD 1 Quarter
Repayments of long-term debt RepaymentsOfLinesOfCredit $33.12M USD 1 Quarter
Contingent consideration payments PaymentForContingentConsiderationLiabilityFinancingActivities - USD 1 Quarter
Contingent consideration payments PaymentForContingentConsiderationLiabilityFinancingActivities $700.00K USD 1 Quarter
Other financing activity ProceedsFromPaymentsForOtherFinancingActivities $-23.25M USD 1 Quarter
Other financing activity ProceedsFromPaymentsForOtherFinancingActivities $-4.89M USD 1 Quarter
Net cash provided by (used in) financing activities NetCashProvidedByUsedInFinancingActivities $-39.68M USD 1 Quarter
Net cash provided by (used in) financing activities NetCashProvidedByUsedInFinancingActivities $-34.93M USD 1 Quarter
Effect of exchange rate changes on cash and cash equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $-4.40M USD 1 Quarter
Effect of exchange rate changes on cash and cash equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $-159.00K USD 1 Quarter
Net change in cash and cash equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect $-2.77M USD 1 Quarter
Net change in cash and cash equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect $22.78M USD 1 Quarter
Cash and cash equivalents at beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $169.40M USD Point-in-time
Cash and cash equivalents at beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $196.32M USD Point-in-time
Cash and cash equivalents at beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $199.09M USD Point-in-time
Cash and cash equivalents at beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $146.62M USD Point-in-time
Cash and cash equivalents at end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $169.40M USD Point-in-time
Cash and cash equivalents at end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $196.32M USD Point-in-time
Cash and cash equivalents at end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $199.09M USD Point-in-time
Cash and cash equivalents at end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $146.62M USD Point-in-time
Cash paid for income taxes IncomeTaxesPaid $6.03M USD 1 Quarter
Cash paid for income taxes IncomeTaxesPaid $12.07M USD 1 Quarter
Cash paid for interest InterestPaidNet $3.11M USD 1 Quarter
Cash paid for interest InterestPaidNet $4.24M USD 1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.

NEWS
Loading news...
TRENDING
Loading...